Global hunt for long COVID relief: can old drugs solve a new problem?

NCT ID NCT06928272

Recruiting now Symptom relief Sponsor: Douglas D. Fraser Source: ClinicalTrials.gov ↗

Summary

This large, international study is testing if two medications already used for other conditions can help people suffering from Long COVID. About 348 adults with Long COVID symptoms for at least three months will take either one of the drugs or a placebo for three months. The main goal is to see if the treatments can improve key symptoms like severe fatigue, breathing problems, brain fog, muscle pain, and poor circulation.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre de Recherche du CHUS (CRCHUS)
RECRUITING

Sherbrooke, Quebec, J1H 5N4, Canada
INMI Lazzaro Spallanzani IRCCS
NOT_YET_RECRUITING

Roma, Roma, 00149, Italy
Ini-Fiocruz
NOT_YET_RECRUITING

Rio de Janeiro, Rio de Janerio, 21040-900, Brazil
Institut de Recherches Cliniques de Montréal (IRCM)
RECRUITING

Montreal, Quebec, H2W 1R7, Canada
Joint Clinical Research Centre (JCRC)
NOT_YET_RECRUITING

Kampala, Kampala, 10005, Uganda
Laura Rodriguez Research Institute
RECRUITING

San Diego, California, 92101, United States
Sapienza Università di Roma
NOT_YET_RECRUITING

Roma, Roma, 00185, Italy
University Teaching Hospital
NOT_YET_RECRUITING

Lusaka, Lusaka Province, 10100, Zambia

Conditions

Explore the condition pages connected to this study.

LONG COVID